Recombinant Rat IFN- Gamma (carrier-free) 25 µg
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
IFN-γ is a key component of the immune response to viral infections. It is produced by NK, NKT, and γ/δ T cells during early stages of infection and by CD4 and CD8 T cells later during the adaptive immune response. During infection, the role of IFN-γ includes protection, clearance, and modulation of the immune response. IFN-γ modulates epithelial cell functions and may play a role in intestinal wound healing as it might help preserve the integrity of the intestinal epithelium. It has been published that IFN-γ enhances IL-27 secretion, and the treatment of rats in a model of arthritis, IFN-γ/IL-27 successfully controlled arthritic inflammation and inhibited mediators of inflammation, angiogenesis, cell survival, apoptosis, and tissue damage. Nevertheless, IFN-γ has been associated with multiple inflammatory and autoimmune diseases such as arthritis, lupus nephritis, diabetic retinopathy, lung fibrosis, allergic conjunctivitis, and pediatric SLE. Rat IFN-γ protein has 39% homology with humans and 85% homology with mice proteins. Due to the high homology between rat and mouse IFN-γ, there is a strong affinity for rat IFN-γ on mouse cells.;
Garantie
Garantie 0 Mois
Description
IFN-γ is a key component of the immune response to viral infections. It is produced by NK, NKT, and γ/δ T cells during early stages of infection and by CD4 and CD8 T cells later during the adaptive immune response. During infection, the role of IFN-γ includes protection, clearance, and modulation of the immune response. IFN-γ modulates epithelial cell functions and may play a role in intestinal wound healing as it might help preserve the integrity of the intestinal epithelium. It has been published that IFN-γ enhances IL-27 secretion, and the treatment of rats in a model of arthritis, IFN-γ/IL-27 successfully controlled arthritic inflammation and inhibited mediators of inflammation, angiogenesis, cell survival, apoptosis, and tissue damage. Nevertheless, IFN-γ has been associated with multiple inflammatory and autoimmune diseases such as arthritis, lupus nephritis, diabetic retinopathy, lung fibrosis, allergic conjunctivitis, and pediatric SLE. Rat IFN-γ protein has 39% homology with humans and 85% homology with mice proteins. Due to the high homology between rat and mouse IFN-γ, there is a strong affinity for rat IFN-γ on mouse cells.;
Caractéristiques
- Fournisseur
- BioLegend Europe BV
- Marque
- BIOLEGEND
- Référence fabricant
- 598804
- Référence distributeur
- 598804
- Vendu par
- 25 μg
- Quantité
- N/A
- Lieu de fabrication
- USA
- Lieu de stockage
- Pays-Bas ou USA
- Soumis à carboglace
- non
- Classement dans le catalogue fournisseur
- Recombinant Protein
- Certification
- RUO
- Type d’application
- culture cellulaire
- Type de produit
- protéine
- Température de conservation (°C)
- -20 ou -70 °C
- Température de transport
- Blue Ice
- Organisme cible
- Rat
- Source biologique
- E. coli
- Seuil de coupure des masses moléculaires MWCO
- The 135 amino acid recombinant protein has a predicted molecular mass of approximately 15.6 kD. The DTT-reduced and non-reduced protein migrate at approximately 14 kD by SDS-PAGE. Da
- Concentration
- 10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration, please enter the lot number in our online tools.
- Pureté
- >95%, as determined by Coomassie stained SDS-PAGE. %
- Matière dangereuse
- Non
- Code douanier
- 38220000
- Classement NCBI
- 25712
- Nomenclature Nacres
- NA.77
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA77
- Nomenclature CNRS
- NA77
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD11AOOO
- Type d'échantillon
- culture cellulaire
- Reprise en cas d’erreur client
- non